InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by WAGENHEIM PHILIP, Director. Director active across 1 companies, notably Immunome Inc.. Aggregated, 2 disclosures have been published. Total volume traded: €406k. The latest transaction was filed on 24 May 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€202,81013,500 shares@ €15.023100.0% of flow
Common Stock
SEC:0001104659-21-072619·
Ideal exit: 18 Feb 2022 (T+270)
€202,81013,500 shares@ €15.0230.0086% mcap50.0% of flow
Common Stock
SEC:0001104659-21-072619:0·
Ideal exit: 18 Feb 2022 (T+270)
2 of 2 declarations
About WAGENHEIM PHILIP
Philip Wagenheim is a Director at Immunome Inc. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for Immunome.
